Evive, Acrotech get FDA nod for Ryzneuta (Efbemalenograstim alfa Injection) for chemo-induced neutropenia Read more
Sathgen Therapeutics announces completion of first cohort in phase 1 clinical trial with anti-cancer drug Read more